About Us

We are TAE Life Sciences

At TAE Life Sciences, our mission is to advance BNCT and investigate its potential as a promising treatment for broad clinical use. The foundation of our revolutionary pathway to treatment is an accelerator-based neutron beam, derived from decades of groundbreaking work by TAE Technologies, Inc., an innovative leader in fusion energy technology.

Leveraging these advances, TAE Life Sciences is developing a holistic clinical platform for the next generation of BNCT: low energy neutron beams capable of catering to unique clinical treatment protocols with the ability to tune beam intensity, coupled with a practical footprint for hospitals or free-standing radiation treatment settings.

We have assembled a world-class, cross-functional team of clinicians, radiation oncologists, physicists and other researchers to enable us to bring our technology to those who need it the most.

  OUR NEUTRON SOURCE
     ABOUT BNCT
  

Meet our Leadership Team

bruce-bauer-mt

Bruce Bauer, PhD

Chief Executive Officer
robert-hill-mt

Robert Hill

Chief Operating Officer
kendall-morrison-mt

Kendall Morrison, PhD

Chief Science Officer
anna-theriault-mt

Anna Theriault

Head of Global Product Strategy and Marketing
robert-kirby-mt

Robert Kirby

Vice President of Regulatory Affairs
chad-lee-mt

Chad Lee, PhD

Director of Clinical Development
barry-bonner-mt

Barry Bonner

Vice President of Business Development, Americas
arnold-dijkstra-mt

Arnold Dijkstra

Vice President of Business Development, EMEA

Meet our Board of Directors

bruce-bauer_2

Bruce Bauer, PhD

Chief Executive Officer, TAE Life Sciences
michl-binderbauer_2

Michl Binderbauer, PhD

Chief Executive Officer, TAE Technologies, Inc.
stuart-peterson_2

Stuart Peterson

Co-Founder and President, ARTIS Ventures
artem-smirnov_2

Artem Smirnov, PhD

Chief Technology Officer, TAE Technologies, Inc.